Join
Live feed
·
PRReleasevia Quantisnow
Perspective Therapeutics Inc. logo

Perspective Therapeutics Granted Fast Track Designation for [212Pb]PSV359 for the Treatment of Adult Patients with Locally Advanced Unresectable and/or Metastatic FAP-Positive Solitary Fibrous Tumors

ByQuantisnow·Wall Street's wire, on your screen.
CATX· Perspective Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CATX (Perspective Therapeutics Inc.) and more on Quantisnow.